Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals, Inc. (ABOS) is a healthcare company (biotechnology) based in the United States. The share price is $0.21, down 3.15% on the day, which values the company at $15.13M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$0.21−3.15% today
Market value
$15.13M
200-week average
$2.8593% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Acumen Pharmaceuticals, Inc. in more detail

ABOS trades at -0.4× next year's expected earnings. It sits 93% below its 200-week average of $2.85.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold ABOS, including Peter Kolchinsky (0.5% of the portfolio).

Superinvestors holding ABOS

1 of the investors tracked here report a position in their latest 13F filing.

Acumen Pharmaceuticals, Inc. (ABOS): questions and answers

What is Acumen Pharmaceuticals, Inc.'s market cap?

Acumen Pharmaceuticals, Inc. is valued at $15.13M at a share price of $0.21.

Is ABOS above its 200-week moving average?

No. ABOS is 92.7% below its 200-week average of $2.85. Long-term investors watch that line because strong companies rarely trade below it for long.

Does ABOS pay a dividend?

Acumen Pharmaceuticals, Inc. does not currently pay a regular dividend.

Which famous investors own ABOS?

In their latest quarterly filings, Peter Kolchinsky (0.5% of the portfolio) hold ABOS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Acumen Pharmaceuticals, Inc. (ABOS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ABOS

Underlying data: Yahoo Finance; company filings with the SEC.